SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-031463
Filing Date
2014-04-29
Accepted
2014-04-29 06:01:31
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-9644_110q.htm 10-Q 1176281
2 EX-31.1 a14-9644_1ex31d1.htm EX-31.1 12905
3 EX-31.2 a14-9644_1ex31d2.htm EX-31.2 12875
4 EX-32.1 a14-9644_1ex32d1.htm EX-32.1 7026
5 EX-32.2 a14-9644_1ex32d2.htm EX-32.2 6989
  Complete submission text file 0001104659-14-031463.txt   10664672

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT uthr-20140331.xml EX-101.INS 1353579
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20140331.xsd EX-101.SCH 110296
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20140331_cal.xml EX-101.CAL 151589
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20140331_def.xml EX-101.DEF 501324
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20140331_lab.xml EX-101.LAB 1802671
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20140331_pre.xml EX-101.PRE 823707
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 14791102
SIC: 2834 Pharmaceutical Preparations